It has been found that doxorubicin-induced cardiomyopathy is mediated, in part, through the production of reactive oxygen species (ROS), which is one method through which TGF-β is activated and which leads to the increased proliferation of fibroblasts [100]. The gene discussed is TGFB1; the disease is cardiomyopathy.